Form D · Other Health Care
3Analytics, Inc.
Cupertino, CA · CIK 0001843997
Offering snapshot reported Feb 25, 2021 · SEC filing
- Reported sold
- $475K Indefinite offering
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- May 20, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 25, 2021 | Initial | $474,996 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-390534
Source: Form D, filed Feb 25, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sushil Jha | Director, Executive |
| Dharani Gokul Munirathinam | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1329 Aster Lane
Cupertino, CA, 95014
Cupertino, CA, 95014